Search

everythinglearnresearchcommunity

for

Search:↓

Vibration assisted analgesia reduces pain during corticosteroid therapy for alopecia.

The paper concludes that recognizing bitemporal alopecia areata is important for early treatment and preventing its progression.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Triamcinolone acetonide is more effective than cryotherapy for hair regrowth in alopecia areata but has different side effects.

Intralesional dutasteride improves hair growth in androgenic alopecia with minimal side effects.

There is no standard treatment for CCCA, and practices vary widely.

Corticosteroid injections for hair loss may cause eye problems, so caution is needed.

Various local treatments for alopecia areata show promise, but individualized plans and more research are needed.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Using lidocaine before keloid injections makes the treatment more comfortable for patients.

Mycophenolate mofetil may improve symptoms and stop hair loss in Lichen planopilaris, but more research is needed.

No treatment alters the natural progression of alopecia areata, and effectiveness varies, with some possibly working better in children.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Mixing platelet-rich plasma with triamcinolone acetonide can potentially improve hair regrowth in alopecia areata patients.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Intradermal testing can better detect corticosteroid allergies than patch testing.

Two patients treated with TAC for mouth fibrosis improved but developed Cushing's Syndrome symptoms.

Pediatric dermatologists have varied preferences for treating alopecia areata in children, with no standard FDA-approved treatments and some using JAK inhibitors despite risks.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Hair transplant for eyebrow alopecia areata provided significant relief and improved treatment response.

Some new treatments for children's skin conditions are effective, but risks must be weighed.

Hair transplants can temporarily help with eyebrow hair loss.

Platelet-rich plasma (PRP) injections successfully treated a woman's steroid-resistant hair loss, causing hair to regrow within a month.

Hair loss was the first sign of a brain-related complication in a woman with lupus, and early treatment helped her hair grow back.

Early treatment can reverse hair loss from dermal fillers.

Dutasteride mesotherapy showed mixed results and is not recommended as a primary treatment for hair loss.

Enzyme injections can effectively treat epidermoid cysts without surgery.